An Effectiveness and Safety Study of Inhaled JNJ 49095397 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease

Update Il y a 4 ans
Reference: EUCTR2012-005184-27

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective is to assess the efficacy (as measured by change from baseline in prebronchodilator [preBD] percent predicted FEV1) of JNJ-49095397 compared with placebo in subjects with symptomatic moderate (GOLD Grade II) to severe (GOLD Grade III) COPD.


Inclusion criteria

  • Moderate to Severe Chronic Obstructive Pulmonary
  • Disease